SLOW FE OTC
Generic Name and Formulations:
Iron 50mg (as sulfate 160mg); sust-rel tabs.
Novartis Consumer Health
Indications for SLOW FE:
Iron deficiency and iron deficiency anemias.
Swallow whole. 1–2 tabs daily; max 4 daily.
Swallow whole. <6 yrs: not recommended. ≥6 yrs: 1 tab daily.
Hepatitis. Pancreatitis. Peptic ulcer or GI inflammation. Achlorhydria. Monitor hematocrit. Folic acid may mask pernicious anemia. Repeated blood transfusions. Elderly.
Inhibits tetracycline absorption.
Nausea, abdominal discomfort and pain, constipation, diarrhea, masks occult bleeding, black stools.
Slow Fe—30, 60, 90; Plus folic acid—20
Endocrinology Advisor Articles
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Behavioral Weight Loss Interventions May Prevent Obesity
- Early Treatment Intensification and Faster Glycemic Control in T2D
- Executive Function Predicts T1D Management Into Emerging Adulthood
- Intensive Blood Pressure Therapy Lowers Cardiovascular Risk in Diabetes
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age
- LVAD in Heart Failure Linked to Improved Glycemic Control
- Fundamental Institutional Change Is Needed to Eliminate Sexual Harassment
- Gestational Diabetes Tied to Subsequent Glucose Disorders
- Association Health Plans Can Help Small Businesses Offer Coverage